Brian Taylor Slingsby - 13 Mar 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Signature
Brian Taylor Slingsby by: /s/ Adam Levy, Attorney-in-fact
Issuer symbol
MLYS
Transactions as of
13 Mar 2025
Net transactions value
+$3,499,996
Form type
4
Filing time
25 Apr 2025, 19:01:59 UTC
Previous filing
24 Feb 2025
Next filing
21 Nov 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Purchase $3,499,996 +259,259 +3% $13.50 8,903,838 13 Mar 2025 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.